2Heutling D, Schulz H, Nichel I, et al. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatmeat[ J]. J Clin Endoerinol Metab,2008,93:82-90.
3Ozgurtas T, Oktenli C, Dede M, et al. Metformin and oral contraceptive treatments reduced circulating asymmetrical dimethylarginine, levels in patients with polycystic ovary syndrome[ J]. Atherosclerosis ,2008,200:336-344.
4Kowalska I,Straczkowski M,Nikolajuk A,et al. Serum visfatin in relation to insulin resistance and markers of hyperandro genism in lean and obese women with polycystic ovary syndrome[ J]. Hum Reprod ,2007,22 : 1824-1829.
4Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of irsulin[J].Science,2005,307 (5708):426-430.
5Matsuzawa Y.Therapy Insight:edipoeytokines in metabolic syndrome and related cardiovascular disease[J].Nat Clin Pract Cardiovase Med,2006,3(1):35-42.
6Sandeep S,Velmumgan K,Deepa R,et al.Serum visfatin in relation to visceral fat,obesity,and type 2 diabetes mellitus in Asian Indians[J].Metabolism,2007,56(4):565-570.
7Tan BK,Chen J,Digby JE,et al.Increased Visfatin mRNA and Protein Levels in Adipose Tissue and Adipocytes in Women with Polyeystie Ovary Syndrome:Parallel Increase in Plasma Visfatin[J].J Clin Endocrin Metab,2006,91(12):5022-5028.
8Chan TF,Chen YL,Chen HH,et al.Increased plasma visfatin concentration in women with polycystic ovary syndrome[J].Fertil Steril,2007,88(2):401-405.
9Kowalska I,Straczkowski M,Nikolajuk A,et al.Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome[J].Hum Repred,2007,22(7):1824-1829.
10Berndt J,Klating N,Kralisch S,et al.Plasma vlsfatin concentrations and fat depot-specific mRNA expression in humans[J].Diabetes,2005,54(10):2911-2916.
1Ozgurtas T, Okten li C, Dede M, et al. M effo rm in and ora 1 contraceptive treatments reduced circulating asymmetrical dim ethy- larginine, leve Is in patients with polycystic ovary syndrome [J]. Atherosclerosis, 2008, 200: 336-344.
2Alireza Esteghamati,Azam Alamdari,Ali Zandieh,Seerat Elahi,Omid Khalilzadeh,Manouchehr Nakhjavani,Alipasha Meysamie.Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity[J].Diabetes Research and Clinical Practice.2010(2)
3Ching-Ju Shen,Eing-Mei Tsai,Jau-Nan Lee,Yi-Ling Chen,Chien-Hung Lee,Te-Fu Chan.The concentrations of visfatin in the follicular fluids of women undergoing controlled ovarian stimulation are correlated to the number of oocytes retrieved[J].Fertility and Sterility.2010(6)
